MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517044350 A) filed by Abtis Co. Ltd.; and Research & Business Foundation Sungkyunkwan University, Gyeonggi, Republic of Korea, on May 7, for 'antibody-drug conjugate comprising anti-claudin-18.2 antibody, and therapeutic use thereof for cancer.'
Inventor(s) include Chung, Sang Jeon; Oh, Yeong Soo; Kim, Juhwan; Lee, Younggeun; Seo, Jinwoo; Lee, Geonmin; Kim, Gahyeon; Kwon, Sejeong; Park, Sunhee; Yeom, Hojin; Oh, Hui Jo; and Son, Jinyoung.
The application for the patent was published on May 30, under issue no. 22/2025.
According to the abstract released by the Intellectual Property India: "The present application relates to an antibody-drug conjugate and use thereof."
The patent application was internationally filed on Nov. 01, 2023, under International application No.PCT/KR2023/017242.
Disclaimer: Curated by HT Syndication.
